Skip to main content
See every side of every news story
Published • loading... • Updated

AbbVie Inks up to $2.54B Bispecific Cancer Drug Deal with DISCO Pharma

Summary by Seeking Alpha
AbbVie (ABBV) has agreed to pay up to $2.54B to collaborate with Germany-based biotech DISCO Pharmaceuticals on the development of novel cancer treatments.

4 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal